Statins ‘slash risk of prostate cancer returning by 30%’
Statins ‘slash risk of prostate cancer returning by 30%’
Higher doses of the drugs were associated with a lower risk of showing signs of cancer re-growth, according to research.
Read more on Daily Mail
Related posts: